Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Biochemical Society Transactions
|
May 18, 2000
The molecular basis of lysosomal storage diseases and their treatment
B Winchester, A Vellodi, E Young
Journal of Inherited Metabolic Disease
|
May 20, 2005
Evaluation of three biochemical markers in the monitoring of Gaucher disease
A Vellodi, Y Foo, T J Cole
Journal of Clinical Pharmacology
|
November 1, 1987
Hemiplegia and focal convulsions as a manifestation of cyclosporine A toxicity
A Vellodi, R Jayatunga, K Hugh-Jones
Clinical Radiology
|
January 30, 2004
Gaucher disease in children: radiology of non-central nervous system manifestations
K McHugh, Ø E Olsen E, A Vellodi
Spine
|
November 29, 2001
Anterior instrumented fusion for thoracolumbar kyphosis in mucopolysaccharidosis
S S Dalvie, M H Noordeen, A Vellodi
Journal of Pediatric Orthopedics. Part B
|
January 27, 2000
Orthopaedic manifestations of mucolipidosis III: an illustrative case
F S Haddad, R A Hill, A Vellodi
Journal of Inherited Metabolic Disease
|
August 1, 1997
Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase
E Young, C Chatterton, A Vellodi, et al.
Neuropediatrics
|
March 8, 2000
Ocular motor abnormalities in Gaucher disease
C M Harris, D S Taylor, A Vellodi
Archives of Disease in Childhood
|
September 1, 1995
Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation
M A Gatzoulis, A Vellodi, A N Redington
Journal of Inherited Metabolic Disease
|
March 26, 2009
Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapy
M Wood, M A Cleary, L Alderson, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Biochemical Society Transactions
|
May 18, 2000
The molecular basis of lysosomal storage diseases and their treatment
B Winchester, A Vellodi, E Young
Journal of Inherited Metabolic Disease
|
May 20, 2005
Evaluation of three biochemical markers in the monitoring of Gaucher disease
A Vellodi, Y Foo, T J Cole
Journal of Clinical Pharmacology
|
November 1, 1987
Hemiplegia and focal convulsions as a manifestation of cyclosporine A toxicity
A Vellodi, R Jayatunga, K Hugh-Jones
Clinical Radiology
|
January 30, 2004
Gaucher disease in children: radiology of non-central nervous system manifestations
K McHugh, Ø E Olsen E, A Vellodi
Spine
|
November 29, 2001
Anterior instrumented fusion for thoracolumbar kyphosis in mucopolysaccharidosis
S S Dalvie, M H Noordeen, A Vellodi
Journal of Pediatric Orthopedics. Part B
|
January 27, 2000
Orthopaedic manifestations of mucolipidosis III: an illustrative case
F S Haddad, R A Hill, A Vellodi
Journal of Inherited Metabolic Disease
|
August 1, 1997
Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase
E Young, C Chatterton, A Vellodi, et al.
Neuropediatrics
|
March 8, 2000
Ocular motor abnormalities in Gaucher disease
C M Harris, D S Taylor, A Vellodi
Archives of Disease in Childhood
|
September 1, 1995
Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation
M A Gatzoulis, A Vellodi, A N Redington
Journal of Inherited Metabolic Disease
|
March 26, 2009
Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapy
M Wood, M A Cleary, L Alderson, et al.
Page
of 6